In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Barrx Medical closes $27.8mm Series C round

01 Aug 2006

Executive Summary

Barrx Medical (developing devices to treat Barrett's esophagus) raised $27.8mm in its Series C financing led by first-time backer Montagu Newhall Associates with additional participation from returning shareholders Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, and Sutter Hill Ventures. An unnamed private equity firm and individual investors also joined the round. Barrx plans to use the money to manufacture its HALO360 and HALO90 ablation systems and develop a next-generation HALO90.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By